Eutilex.Co.,Ltd (KOSDAQ:263050)

South Korea · Delayed Price · Currency is KRW

959.00

+221.00 (29.95%)

At close: Feb 6, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals		131.65M	215.66M	73.54M	2.04B	408.88M
Pharmaceuticals Growth		-38.95%	193.25%	-96.39%	398.02%	1.70%
Total		131.65M	215.66M	73.54M	2.04B	408.88M
Total Growth		-38.95%	193.25%	-96.39%	398.02%	1.70%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
South Korea		501.08M	215.66M	39.32M	17.73M	12.75M
South Korea Growth		132.35%	448.53%	121.75%	39.11%	-
China		39.30M	-	34.23M	2.02B	396.13M
China Growth		-	-	-98.30%	409.57%	-
Total		540.38M	215.66M	73.54M	2.04B	408.88M
Total Growth		150.57%	193.25%	-96.39%	398.02%	-

Source: S&P Global Market Intelligence.